Neurology: Volume 83, Number 9, August 26, 2014
About this course
- Released: 08/26/2014
- Expires: 08/26/2017
GROWTH HORMONE TREATMENT FOR CHILDHOOD SHORT STATURE AND RISK OF STROKE IN EARLY ADULTHOOD
LEARNING OBJECTIVES:
Upon completion of the article by Poidvin et al, the participant should be able to:
- Recognize that little is currently known about the long-term outcome after growth hormone (GH) treatment in childhood
- Discuss the findings from previous studies regarding the risk of stroke related to acromegaly as well as short stature
- Discuss the findings from this study examining the relationship between exposure to GH treatment during childhood and the risk of stroke in early adulthood
- Discuss the possible implications of the findings of this study with regard to patient counseling
CORE COMPETENCIES:
The article by Poidvin et al covers the following core competency:
- Medical Knowledge
ASPIRIN FOR ACUTE STROKE OF UNKNOWN ETIOLOGY IN RESOURCE-LIMITED SETTINGS: A DECISION ANALYSIS
LEARNING OBJECTIVES:
Upon completion of the article by Berkowitz et al, the participant should be able to:
- Recognize that the global burden of stroke-related disability and mortality falls disproportionately on medical resource-limited low-income countries
- Recognize that one reason that aspirin is used less often for patients with acute stroke in low-income countries is because CT is often unavailable to distinguish ischemic stroke (IS) from intracerebral hemorrhage (ICH)
- Discuss the findings from this decision analysis with regard to the expected outcomes of administering aspirin to all patients with acute stroke when it is unknown whether the etiology is IS or ICH
CORE COMPETENCIES:
The article by Berkowitz et al covers the following core competency:
- Systems-Based Practice
- Medical Knowledge
AUTHOR DISCLOSURES:
Refer to Information and Author section available in the Tool Bar for each article.
THIS PAGE IS REQUIRED READING BEFORE BEGINNING ALL ACCME-ACCREDITED COURSES
ACCREDITATION STATEMENT
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed. Physicians should only claim credit commensurate with the extent of their participation in the activity. The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
MISSION STATEMENT/PROGRAM OBJECTIVES
After evaluating a specific article published in Neurology, participants in the CME activity should be able to demonstrate an increase in, or affirmation of, their knowledge of clinical medicine. Participants should be able to evaluate the appropriateness of the clinical information as it applies to the provision of patient care.
PARTICIPANTS
This program is designed for physicians who are involved in providing patient care and who wish to advance their current knowledge of clinical medicine.
CREDITS
The American Academy of Neurology designates that participants will receive 1.5 AMA PRA Category 1 CME credits if both CME courses for the issue are completed.
The American Academy of Neurology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to sponsor continuing medical education for physicians.
DISCLOSURES
Steven Lewis, MD receives a stipend in his editorial capacity for Neurology and as an Associate Editor for Continuum: Lifelong Learning in Neurology; has received royalties for the books Field Guide to the Neurologic Examination and Neurology for the Non-Neurologist; and anticipates receiving royalties for the book Neurologic Disorders due to Systemic Disease. James WM Owens Jr. MD, PhD receives royalties from UpToDate, Waltham, MA; grant support from NIH (PI, K08NS054882); and a stipend in his editorial capacity for Neurology.
COMMERCIAL SUPPORT
This CME program receives no commercial support.
